The Impact of Compound Danshen Dropping Pills (CDDP) on the Post-myocardial Infarction Ventricular Remodeling
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 268 participants.
Also called NCT05000411
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 268 participants
- Registry
-
NCT05000411
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05000411. Randomized; double masking; primary purpose treatment. Start 2021-08-25 (actual); primary completion 2023-08-25 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Impact of Compound Danshen Dropping Pills (CDDP) on the Post-myocardial Infarction Ventricular Remodeling
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Compound Danshen Dropping Pills (CDDP)
- Intervention (Drug)
- Placebo
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
Record details
- Record id
cardio:ct-nct05000411- Content hash
6b8c965ef1a227d2e00a01bd00ee8a085f8e36027b5642b1badf2e3bbea9147f